BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25630783)

  • 1. Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome. A rare stroke experience.
    Loharia JJ; Alam JM; Abdelhadi HA; Marei TF
    Neurosciences (Riyadh); 2015 Jan; 20(1):55-60. PubMed ID: 25630783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous thrombolysis in SLE-related stroke: a case report and literature review.
    Chen X; Xu G
    Neurol Sci; 2018 Jan; 39(1):155-159. PubMed ID: 29116545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for acute stroke in patient with systemic lupus erythematosus: A case report.
    Majdak MR; Vuletić V
    J Neurol Sci; 2016 Feb; 361():7-8. PubMed ID: 26810507
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Acute Ischemic Stroke.
    Rabinstein AA
    Continuum (Minneap Minn); 2017 Feb; 23(1, Cerebrovascular Disease):62-81. PubMed ID: 28157744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
    J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
    Kremer C; Kappelin J; Perren F
    J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.
    Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH
    Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
    Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful intravenous thrombolysis in a patient with antiphospholipid syndrome, acute ischemic stroke and severe thrombocytopenia.
    Camara-Lemarroy CR; Infante-Valenzuela A; Andrade-Vazquez CJ; Enriquez-Noyola RV; Garcia-Valadez EA; Gongora-Rivera F
    Blood Coagul Fibrinolysis; 2016 Apr; 27(3):354-6. PubMed ID: 26575492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful intravenous thrombolysis in a stroke patient with hemiballism.
    Zidverc-Trajković J; Jovanović DR; Marjanović I; Radojičić A; Beslać-Bumbaširević L
    Neurologist; 2011 Jul; 17(4):205-7. PubMed ID: 21712665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional endovascular therapy in patients with acute ischemic stroke who are nonresponsive to intravenous tissue plasminogen activator: usefulness of magnetic resonance angiography-diffusion mismatch.
    Dembo T; Deguchi I; Fukuoka T; Nagoya H; Maruyama H; Kato Y; Horiuchi Y; Ohe Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1056-63. PubMed ID: 22902147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis.
    Kim HS; Lee DH; Choi CG; Kim SJ; Suh DC
    AJR Am J Roentgenol; 2006 Dec; 187(6):W650-7. PubMed ID: 17114520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.